Oscar Health (OSCR) is back in focus after management lifted its 2026 operating earnings outlook, reported record profitability, and paired that with rapid membership and revenue expansion across its health insurance platform.
The latest operating outlook upgrade lands on top of a powerful run in the shares, with a 90 day share price return of 18.92% and a year to date share price gain of 129.26% around a US$34.32 quote. A 1 year total shareholder return of 66.04% sits against a very large 3 year total shareholder return that suggests longer term investors have already experienced substantial swings in value, so recent momentum appears to be building rather than fading as earnings headlines and estimate revisions reshape how investors price Oscar Health’s risks and potential rewards.
Scan for other insurers showing Oscar Health style momentum by starting with our curated list of list of solid balance sheet and fundamentals (25 results), which could handle similar growth pressures.
Oscar Health now screens as a stronger business, with record profitability and raised 2026 targets. Yet the share price near US$34 still leaves one key issue open: Does that strength already sit in the valuation?
Most Popular Narrative: 94% Undervalued
On the most followed valuation story, Oscar Health screens as deeply discounted, with a fair value of $583.34 against a recent $34.32 share price. This puts an aggressive upside case on the table that some investors are treating as the key lens on this move.
Every so often, a ticker flashes on my screen that makes me stop and rub my eyes. It is the kind of number that looks like a mistake, like you thought you were getting clothes on Christmas Day, but then your parents surprise you by hiding the PlayStation 2 you've been wanting for months in the other room...
The screen showed Oscar Health. Ridiculous name for a health insurance company, but the numbers are anything but.
See why 11 investors see Oscar Health as 94% undervalued.
Result: Fair Value of $583.34 (UNDERVALUED)
Still, the Oscar Health story can crack if growth assumptions in that DCF prove too optimistic, or if margins and cash conversion fail to match the narrative.
Find out about the key risks to this Oscar Health narrative.
Next Steps
Big upside stories like Oscar Health can easily sway sentiment, so move quickly, look through the full picture, and weigh both sides with the 2 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Oscar Health?
If Oscar Health has your attention, broaden your watchlist now so you do not miss other opportunities that could suit your risk profile and return goals.
- Target potential mispricings by scanning the 32 high quality undervalued stocks that currently combine solid fundamentals with compressed expectations.
- Strengthen your income stream by reviewing the 7 dividend fortresses that aim to pair higher yields with resilient cash flows.
- Calm portfolio volatility by focusing on the 32 resilient stocks with low risk scores that show steadier fundamentals and more measured risk scores.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com